HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
Titel:
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
Auteur:
Foo, Caroline S. Abdelnabi, Rana Kaptein, Suzanne J.F. Zhang, Xin ter Horst, Sebastiaan Mols, Raf Delang, Leen Rocha-Pereira, Joana Coelmont, Lotte Leyssen, Pieter Dallmeier, Kai Vergote, Valentijn Heylen, Elisabeth Vangeel, Laura Chatterjee, Arnab K. Annaert, Pieter P. Augustijns, Patrick F. De Jonghe, Steven Jochmans, Dirk Gouwy, Mieke Cambier, Seppe Vandooren, Jennifer Proost, Paul van Laer, Christine Weynand, Birgit Neyts, Johan